Skip to content
10-K

Annual Report

US-BLH BIO-ENGINEERING INT'L, INC.

0001078782-14-000322

← back to feed
Filed
Mar 5, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Feb 10, 2014 54.52M sh
Stock Repurchased FY 2012 · Dec 31, 2012 $719
Stock Repurchased FY 2012 · Dec 31, 2012 $719
Dividends Paid FY 2012 · Dec 31, 2012 $19.23K
Dividends Paid FY 2012 · Dec 31, 2011 $19.23K
Stockholders Equity FY 2012 · Dec 31, 2012 −$5.06K
Stockholders Equity FY 2012 · Dec 31, 2011 $17.4K
Stockholders Equity FY 2012 · Dec 31, 2010 −$332
Current Liabilities FY 2012 · Dec 31, 2012 $5.06K
Current Liabilities FY 2012 · Dec 31, 2011 $950
Sga Expense FY 2012 · Dec 31, 2012 $20.88K
Sga Expense FY 2012 · Dec 31, 2012 $65.81K
Sga Expense FY 2012 · Dec 31, 2011 $44.59K
Net Income FY 2012 · Dec 31, 2012 −$21.73K
Net Income FY 2012 · Dec 31, 2012 −$67.61K
Net Income FY 2012 · Dec 31, 2011 −$45.54K
Net Income FY 2012 · Dec 31, 2010 −$332
Operating Income FY 2012 · Dec 31, 2012 −$20.88K
Operating Income FY 2012 · Dec 31, 2012 −$65.81K
Operating Income FY 2012 · Dec 31, 2011 −$44.59K
Cash And Equivalents FY 2012 · Dec 31, 2011 $18.35K
Current Assets FY 2012 · Dec 31, 2011 $18.35K
Total Assets FY 2012 · Dec 31, 2011 $18.35K